PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Since multiple studies have demonstrated that PET can identify responders and non-responders
to induction chemotherapy, using FDG-PET imaging to guide treatment decisions has prompted
interest in clinical practice. The aim of this study was to evaluate whether changing
chemotherapy regimen during radiation based on PET response to induction chemotherapy can
improve clinical complete response (cCR) in patients with unresectable esophageal squamous
cell carcinoma (ESCC).